Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor

Hao Yan, Mengyao Wu, Yan Yuan, Zack Z. Wang, Hua Jiang, Tong Chen

Research output: Contribution to journalArticle

Abstract

Mesenchymal stem cells (MSCs) can be polarized into two distinct populations, MSC1 and MSC2, by activation of different Toll-like receptors (TLRs). TLR4-primed MSC1 expressed proinflammatory factors, whereas TLR3-primed MSC2 expressed suppressive factors. However, little is known about the function of TLRs on B lymphocyte-related immune modulation. In this study, we investigated the expression of B cell activating factor (BAFF), a member of the tumor necrosis factor ligand superfamily with notable stimulating activity on B cells, in human MSCs (hMSCs) and in murine MSCs (mMSCs) after activation of TLRs. BAFF was increasingly expressed in presence of TLR4 agonist (lipopolysaccharide, LPS), while TLR2 agonist (Zymosan) and TLR3-agonist (polyinocinic-polycytidykic acid, poly I:C) had no effect on BAFF expression. In addition, we demonstrated that signaling pathways of NF-κB, p38 MAPK, and JNK were involved in TLR4-primed BAFF expression. Our results suggested that TLR4 and downstream pathways in MSCs exert an important function in B lymphocyte-related immune regulation. Further defining a homogeneous population of MSCs should provide insight into MSC-based immune-modulating therapy.

Original languageEnglish (US)
Pages (from-to)212-217
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume448
Issue number2
DOIs
StatePublished - May 30 2014

Fingerprint

B-Cell Activating Factor
Toll-Like Receptor 4
Stem cells
Mesenchymal Stromal Cells
Toll-Like Receptors
B-Lymphocytes
Lymphocytes
Tumor Necrosis Factors
Chemical activation
Zymosan
p38 Mitogen-Activated Protein Kinases
Population
Lipopolysaccharides
Cells
Modulation
Acids

Keywords

  • BAFF
  • LPS
  • Mesenchymal stem cell
  • Pro-inflammatory
  • TLR4

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor. / Yan, Hao; Wu, Mengyao; Yuan, Yan; Wang, Zack Z.; Jiang, Hua; Chen, Tong.

In: Biochemical and Biophysical Research Communications, Vol. 448, No. 2, 30.05.2014, p. 212-217.

Research output: Contribution to journalArticle

@article{565b969ba3f54a89b78fff516dd09532,
title = "Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor",
abstract = "Mesenchymal stem cells (MSCs) can be polarized into two distinct populations, MSC1 and MSC2, by activation of different Toll-like receptors (TLRs). TLR4-primed MSC1 expressed proinflammatory factors, whereas TLR3-primed MSC2 expressed suppressive factors. However, little is known about the function of TLRs on B lymphocyte-related immune modulation. In this study, we investigated the expression of B cell activating factor (BAFF), a member of the tumor necrosis factor ligand superfamily with notable stimulating activity on B cells, in human MSCs (hMSCs) and in murine MSCs (mMSCs) after activation of TLRs. BAFF was increasingly expressed in presence of TLR4 agonist (lipopolysaccharide, LPS), while TLR2 agonist (Zymosan) and TLR3-agonist (polyinocinic-polycytidykic acid, poly I:C) had no effect on BAFF expression. In addition, we demonstrated that signaling pathways of NF-κB, p38 MAPK, and JNK were involved in TLR4-primed BAFF expression. Our results suggested that TLR4 and downstream pathways in MSCs exert an important function in B lymphocyte-related immune regulation. Further defining a homogeneous population of MSCs should provide insight into MSC-based immune-modulating therapy.",
keywords = "BAFF, LPS, Mesenchymal stem cell, Pro-inflammatory, TLR4",
author = "Hao Yan and Mengyao Wu and Yan Yuan and Wang, {Zack Z.} and Hua Jiang and Tong Chen",
year = "2014",
month = "5",
day = "30",
doi = "10.1016/j.bbrc.2014.04.097",
language = "English (US)",
volume = "448",
pages = "212--217",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor

AU - Yan, Hao

AU - Wu, Mengyao

AU - Yuan, Yan

AU - Wang, Zack Z.

AU - Jiang, Hua

AU - Chen, Tong

PY - 2014/5/30

Y1 - 2014/5/30

N2 - Mesenchymal stem cells (MSCs) can be polarized into two distinct populations, MSC1 and MSC2, by activation of different Toll-like receptors (TLRs). TLR4-primed MSC1 expressed proinflammatory factors, whereas TLR3-primed MSC2 expressed suppressive factors. However, little is known about the function of TLRs on B lymphocyte-related immune modulation. In this study, we investigated the expression of B cell activating factor (BAFF), a member of the tumor necrosis factor ligand superfamily with notable stimulating activity on B cells, in human MSCs (hMSCs) and in murine MSCs (mMSCs) after activation of TLRs. BAFF was increasingly expressed in presence of TLR4 agonist (lipopolysaccharide, LPS), while TLR2 agonist (Zymosan) and TLR3-agonist (polyinocinic-polycytidykic acid, poly I:C) had no effect on BAFF expression. In addition, we demonstrated that signaling pathways of NF-κB, p38 MAPK, and JNK were involved in TLR4-primed BAFF expression. Our results suggested that TLR4 and downstream pathways in MSCs exert an important function in B lymphocyte-related immune regulation. Further defining a homogeneous population of MSCs should provide insight into MSC-based immune-modulating therapy.

AB - Mesenchymal stem cells (MSCs) can be polarized into two distinct populations, MSC1 and MSC2, by activation of different Toll-like receptors (TLRs). TLR4-primed MSC1 expressed proinflammatory factors, whereas TLR3-primed MSC2 expressed suppressive factors. However, little is known about the function of TLRs on B lymphocyte-related immune modulation. In this study, we investigated the expression of B cell activating factor (BAFF), a member of the tumor necrosis factor ligand superfamily with notable stimulating activity on B cells, in human MSCs (hMSCs) and in murine MSCs (mMSCs) after activation of TLRs. BAFF was increasingly expressed in presence of TLR4 agonist (lipopolysaccharide, LPS), while TLR2 agonist (Zymosan) and TLR3-agonist (polyinocinic-polycytidykic acid, poly I:C) had no effect on BAFF expression. In addition, we demonstrated that signaling pathways of NF-κB, p38 MAPK, and JNK were involved in TLR4-primed BAFF expression. Our results suggested that TLR4 and downstream pathways in MSCs exert an important function in B lymphocyte-related immune regulation. Further defining a homogeneous population of MSCs should provide insight into MSC-based immune-modulating therapy.

KW - BAFF

KW - LPS

KW - Mesenchymal stem cell

KW - Pro-inflammatory

KW - TLR4

UR - http://www.scopus.com/inward/record.url?scp=84901589224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901589224&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2014.04.097

DO - 10.1016/j.bbrc.2014.04.097

M3 - Article

C2 - 24780395

AN - SCOPUS:84901589224

VL - 448

SP - 212

EP - 217

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -